Literature DB >> 33488541

Predicted Structural Variability of Mycobacterium tuberculosis PPE18 Protein With Immunological Implications Among Clinical Strains.

Jill M C Hakim1, Zhenhua Yang1.   

Abstract

Recent advancements in vaccinology have led to the development of the M72/AS01E subunit vaccine, of which the major component is the Mycobacterium tuberculosis (MTB) PPE18 protein. Previous studies have demonstrated the genetic variability of the gene encoding PPE18 protein and the resulting peptide changes in diverse clinical strains of MTB; however, none have modeled the structural changes resulting from these peptide changes and their immunological implications. In this study, we investigated the structural predictions of 29 variant PPE18 proteins previously reported. We found evidence that PPE18 is at least a two-domain protein, with a highly conserved first domain and a largely variable second domain that has different coevolutionary clusters. Further, we investigated putative epitope sites in the clinical variants of PPE18 using prediction software. We found a negative relationship between T-cell epitope number and residue variability, while B-cell epitope likelihood was positively correlated with residue variability. Moreover, we found far more residues in the second domain predicted to be B-cell epitopes compared with the first domain. These results suggest an important functional role of the first domain and a role in immune evasion for the second, which extends our knowledge base of the basic biology of the PPE18 protein and indicates the need for further study into non-traditional immunological responses to TB.
Copyright © 2021 Hakim and Yang.

Entities:  

Keywords:  Mycobacterium tuberculosis; PPE18; epitope prediction; immune evasion; in silico structural prediction

Year:  2021        PMID: 33488541      PMCID: PMC7819968          DOI: 10.3389/fmicb.2020.595312

Source DB:  PubMed          Journal:  Front Microbiol        ISSN: 1664-302X            Impact factor:   5.640


  39 in total

1.  Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination.

Authors:  S Sreevatsan; X Pan; K E Stockbauer; N D Connell; B N Kreiswirth; T S Whittam; J M Musser
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

Review 2.  Prospects for a better vaccine against tuberculosis.

Authors:  S G Reed; M R Alderson; W Dalemans; Y Lobet; Y A W Skeiky
Journal:  Tuberculosis (Edinb)       Date:  2003       Impact factor: 3.131

3.  Immune recognition surface construction of Mycobacterium tuberculosis epitope-specific antibody responses in tuberculosis patients identified by peptide microarrays.

Authors:  Davide Valentini; Martin Rao; Giovanni Ferrara; Marc Perkins; Ernest Dodoo; Alimuddin Zumla; Markus Maeurer
Journal:  Int J Infect Dis       Date:  2017-02-10       Impact factor: 3.623

4.  Origins of coevolution between residues distant in protein 3D structures.

Authors:  Ivan Anishchenko; Sergey Ovchinnikov; Hetunandan Kamisetty; David Baker
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-07       Impact factor: 11.205

5.  Conservation of coevolving protein interfaces bridges prokaryote-eukaryote homologies in the twilight zone.

Authors:  Juan Rodriguez-Rivas; Simone Marsili; David Juan; Alfonso Valencia
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-13       Impact factor: 11.205

6.  Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology.

Authors:  J D van Embden; M D Cave; J T Crawford; J W Dale; K D Eisenach; B Gicquel; P Hermans; C Martin; R McAdam; T M Shinnick
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

7.  Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution.

Authors:  Todd M Allen; Marcus Altfeld; Shaun C Geer; Elizabeth T Kalife; Corey Moore; Kristin M O'sullivan; Ivna Desouza; Margaret E Feeney; Robert L Eldridge; Erica L Maier; Daniel E Kaufmann; Matthew P Lahaie; Laura Reyor; Giancarlo Tanzi; Mary N Johnston; Christian Brander; Rika Draenert; Jurgen K Rockstroh; Heiko Jessen; Eric S Rosenberg; Simon A Mallal; Bruce D Walker
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

8.  Clustering patterns of cytotoxic T-lymphocyte epitopes in human immunodeficiency virus type 1 (HIV-1) proteins reveal imprints of immune evasion on HIV-1 global variation.

Authors:  Karina Yusim; Can Kesmir; Brian Gaschen; Marylyn M Addo; Marcus Altfeld; Søren Brunak; Alexandre Chigaev; Vincent Detours; Bette T Korber
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

9.  Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence.

Authors:  S T Cole; R Brosch; J Parkhill; T Garnier; C Churcher; D Harris; S V Gordon; K Eiglmeier; S Gas; C E Barry; F Tekaia; K Badcock; D Basham; D Brown; T Chillingworth; R Connor; R Davies; K Devlin; T Feltwell; S Gentles; N Hamlin; S Holroyd; T Hornsby; K Jagels; A Krogh; J McLean; S Moule; L Murphy; K Oliver; J Osborne; M A Quail; M A Rajandream; J Rogers; S Rutter; K Seeger; J Skelton; R Squares; S Squares; J E Sulston; K Taylor; S Whitehead; B G Barrell
Journal:  Nature       Date:  1998-06-11       Impact factor: 49.962

10.  Final Analysis of a Trial of M72/AS01E Vaccine to Prevent Tuberculosis.

Authors:  Dereck R Tait; Mark Hatherill; Olivier Van Der Meeren; Ann M Ginsberg; Elana Van Brakel; Bruno Salaun; Thomas J Scriba; Elaine J Akite; Helen M Ayles; Anne Bollaerts; Marie-Ange Demoitié; Andreas Diacon; Thomas G Evans; Paul Gillard; Elizabeth Hellström; James C Innes; Maria Lempicki; Mookho Malahleha; Neil Martinson; Doris Mesia Vela; Monde Muyoyeta; Videlis Nduba; Thierry G Pascal; Michele Tameris; Friedrich Thienemann; Robert J Wilkinson; François Roman
Journal:  N Engl J Med       Date:  2019-10-29       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.